MedTrace Logo

PE-1 in the Diagnosis of Pancreatic Exocrine Insufficiency

NCT05791110 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1053

Last updated 2023-04-13

No results posted yet for this study

Summary

The aim of this study was to evaluate and determine the clinical performance of Fecal Pancreatic Elastase 1 Test in the diagnosis of pancreatic exocrine insufficiency.

Conditions

  • Pancreatic Exocrine Insufficiency

Interventions

DIAGNOSTIC_TEST

Fecal pancreatic elastase 1 test

Fecal pancreatic elastase 1 test are immunoassays for the quantitative determination of fecal pancreatic elastase in human stool samples.

Sponsors & Collaborators

  • Xuanwu Hospital, Beijing

    collaborator OTHER

  • Peking Union Medical College Hospital

    collaborator OTHER

  • Changhai Hospital

    lead OTHER

Principal Investigators

  • zhuan liao · Changhai Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-30
Primary Completion
2021-05-30
Completion
2021-08-26

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05791110 on ClinicalTrials.gov